MACOM counsel Ambra R. Roth sells 9,497 shares
The report lists 15 sale entries separately from the award settlement and tax-withholding transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MACOM Technology Solutions Holdings, Inc. (MTSI) SVP, GC and Secretary Ambra R. Roth sold 9,497 shares of common stock on November 9, 2026, in transactions reported at $212.43 to $230.01 per share. The sales were made under a plan adopted May 21, 2026, intended to comply with Rule 10b5-1. On November 5, performance-based restricted stock units vested and settled in 31,387 shares; 15,688 shares were withheld for related tax obligations. A separate 541-share withholding was reported on November 6 for tax obligations tied to restricted stock units vesting November 8.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F4 | 40 | $212.43 | $8K |
| Sale | Common Stock F4 | 40 | $213.56 | $9K |
| Sale | Common Stock F4, F5 | 80 | $214.98 | $17K |
| Sale | Common Stock F4 | 80 | $217.70 | $17K |
| Sale | Common Stock F4, F6 | 120 | $219.30 | $26K |
| Sale | Common Stock F4, F7 | 280 | $220.69 | $62K |
| Sale | Common Stock F4, F8 | 120 | $222.11 | $27K |
| Sale | Common Stock F4, F9 | 560 | $223.19 | $125K |
| Sale | Common Stock F4, F10 | 760 | $224.11 | $170K |
| Sale | Common Stock F4, F11 | 1,040 | $225.23 | $234K |
| Sale | Common Stock F4, F12 | 1,240 | $226.21 | $281K |
| Sale | Common Stock F4, F13 | 1,240 | $227.23 | $282K |
| Sale | Common Stock F4, F14 | 840 | $228.18 | $192K |
| Sale | Common Stock F4, F15 | 697 | $229.17 | $160K |
| Sale | Common Stock F4, F16 | 2,360 | $230.01 | $543K |
| Tax Withholding | Common Stock F3 | 541 | $210.98 | $114K |
| Grant/Award | Common Stock F1 | 31,387 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F2 | 15,688 | $190.35 | $2.99M |
Footnotes (16)
- F1. Represents performance-based restricted stock units ("PRSUs") previously granted to the Reporting Person under an equity compensation plan maintained by the Issuer, which vested and settled in shares of Common Stock on November 5, 2026.
- F2. Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settling of PRSUs on November 5, 2026.
- F3. Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on November 8, 2026.
- F4. The shares were sold pursuant to a sales plan adopted by the Reporting Person on May 21, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.95 to $215.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $219.04 to $219.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.24 to $221.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $221.52 to $222.46. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $222.56 to $223.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $223.57 to $224.56. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $224.69 to $225.68. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $225.70 to $226.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $226.72 to $227.68. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $227.75 to $228.74. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $228.89 to $229.87. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $230.00 to $230.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
performance-based restricted stock units financial
Rule 10b5-1 regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.